Literature DB >> 312500

Dual control of cell growth by somatomedins and platelet-derived growth factor.

C D Stiles, G T Capone, C D Scher, H N Antoniades, J J Van Wyk, W J Pledger.   

Abstract

Quiescent BALB/c 3T3 cells exposed briefly to a platelet-derived growth factor (PDGF) become "competent" to replicate their DNA but do not "progress" into S phase unless incubated with growth factors contained in platelet-poor plasma. Plasma from hypophysectomized rats is deficient in progression activity; it does not stimulate PDGF-treated competent cells to synthesize DNA, demonstrating that somatomedin C is required for progression. Various growth factors were tested for progression activity and competence activity by using BALB/c 3T3 tissue culture assays. Multiplication stimulating activity and other members of the somatomedin family of growth factors are (like somatomedin C) potent mediators of progression. Other mitogenic agents, such as fibroblast growth factor, are (like PDGF) potent inducers of competence. Growth factors with potent progression activity have little or no competence activity and vice versa. In contrast, simian virus 40 provides both competence and progression activity. Coordinate control of BALB/c 3T3 cell growth in vitro by competence factors and somatomedins may be a specific example of a common pattern of growth regulation in animal tissues.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312500      PMCID: PMC383234          DOI: 10.1073/pnas.76.3.1279

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal.

Authors:  S COHEN
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

2.  A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.

Authors:  W D SALMON; W H DAUGHADAY
Journal:  J Lab Clin Med       Date:  1957-06

3.  Separation of human plasma protein concentrate with insulin activity.

Authors:  H N ANTONIADES
Journal:  Science       Date:  1958-03-14       Impact factor: 47.728

4.  Transforming viruses directly reduce the cellular growth requirement for a platelet derived growth factor.

Authors:  C D Scher; W J Pledger; P Martin; H Antoniades; C D Stiles
Journal:  J Cell Physiol       Date:  1978-12       Impact factor: 6.384

5.  A NERVE GROWTH-STIMULATING FACTOR ISOLATED FROM SNAKE VENOM.

Authors:  S Cohen; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1956-09       Impact factor: 11.205

6.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

Authors:  R W Furlanetto; L E Underwood; J J Van Wyk; A J D'Ercole
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

7.  Complexes of inorganic pyrophosphate, orthophosphate, and calcium as stimulants of 3T3 cell multiplication.

Authors:  H Rubin; H Sanui
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

8.  Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process.

Authors:  W J Pledger; C D Stiles; H N Antoniades; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

Review 9.  How does T antigen transform cells?

Authors:  R A Weinberg
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

10.  Contribution of human somatomedin activity to the serum growth requirement of human skin fibroblasts and chick embryo fibroblasts in culture.

Authors:  A C Moses; K L Cohen; R Johnsonbaugh; S P Nissley
Journal:  J Clin Endocrinol Metab       Date:  1978-06       Impact factor: 5.958

View more
  152 in total

Review 1.  The insulin-like growth factor family of ligands, receptors, and binding proteins.

Authors:  R F Krywicki; D Yee
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Platelet-derived growth factor gene delivery stimulates ex vivo gingival repair.

Authors:  Orasa Anusaksathien; Sarah A Webb; Qi-Ming Jin; William V Giannobile
Journal:  Tissue Eng       Date:  2003-08

3.  Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression.

Authors:  A Sala; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 4.  Growth factor regulation of cell cycle progression in mammary epithelial cells.

Authors:  Malinda A Stull; Anne M Rowzee; Aimee V Loladze; Teresa L Wood
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

5.  Media for cultivation of animal cells: an overview.

Authors:  A Mizrahi; A Lazar
Journal:  Cytotechnology       Date:  1988-07       Impact factor: 2.058

6.  Loss of epidermal growth factor requirement and malignant transformation.

Authors:  P V Cherington; B L Smith; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

7.  beta-catenin mediates insulin-like growth factor-I actions to promote cyclin D1 mRNA expression, cell proliferation and survival in oligodendroglial cultures.

Authors:  Ping Ye; Qichen Hu; Hedi Liu; Yun Yan; A Joseph D'ercole
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

8.  Albumin promotes the progression of fibroblasts through late G1 into S-phase in the absence of growth factors.

Authors:  Sharmeen Uddin; Nataliya Melnyk; David A Foster
Journal:  Cell Cycle       Date:  2020-07-26       Impact factor: 4.534

9.  Characterization of release of basic fibroblast growth factor from bovine retinal endothelial cells in monolayer cultures.

Authors:  R A Brooks; J M Burrin; E M Kohner
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

10.  Mouse NIH 3T3 cells expressing human colony-stimulating factor 1 (CSF-1) receptors overgrow in serum-free medium containing human CSF-1 as their only growth factor.

Authors:  M F Roussel; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.